Synthesis and Antibacterial Activity Evaluation of (2-Chloroquinolin-3-yl)methyleneamino Guanidine Derivatives

被引:6
|
作者
Gao, Zhimin [1 ]
Wang, Tiantian [1 ]
Li, Shenzhen [1 ]
Wan, Huiqi [1 ]
Wang, Gang [1 ]
Wu, Yinbin [1 ]
Deng, Xianqing [1 ]
Song, Mingxia [1 ]
机构
[1] Jinggangshan Univ, Basic Med & Pharm Coll, Jian 343009, Jiangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
alkylene aminoguanidine; 2-chloroquinoline; antibacterial activity; drug-resistance bacteria; BIOLOGICAL EVALUATION; CHEMISTRY;
D O I
10.6023/cjoc201604041
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
In order to find new antibacterial agent with wide spectra and high activities, 8 new (2-chloroquinolin-3-yl)methyleneamino guanidine derivatives were synthesized based on combination principles, whose structures were then identified by spectral methods. All of the compounds provided exhibited good inhibitory activities against the strains chosen, except Salmonella typhimurium 2421 and Pseudomonas aeruginosa 2742, of which MICs were mostly in the range of 2.0 similar to 16 mu g/mL. The compound 4h showed the best broad-spectrum antibacterial activities, whose MIC value was 2.0 mu g/mL against six strains. The inhibitory activities of 4h, against Staphylococcus aureus KCTC 503 and two drug-resistance bacterial (Methicillin-resistant Staphylococcus aureus CCARM 3167 and Quinolone-resistant Staphylococcus aureus CCARM 3505), were superior or equal to positive controls gatifloxacin, moxifloxacin, norfloxacin and oxacillin.
引用
收藏
页码:2484 / 2488
页数:5
相关论文
共 18 条
  • [1] Liposomes as novel anti-infectives targeting bacterial virulence factors?
    da Silveira, Samareh Azeredo
    Perez, Antonio
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2015, 13 (05) : 531 - 533
  • [2] Denny W. A., 2002, [No title captured], Patent No. [WO 2002059122, 2002059122]
  • [3] Synthesis and antimicrobial activities of novel quinoline derivatives carrying 1,2,4-triazole moiety
    Eswaran, Sumesh
    Adhikari, Airody Vasudeva
    Shetty, N. Suchetha
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (11) : 4637 - 4647
  • [4] Guanidine Alkaloids from Monanchora arbuscula: Chemistry and Antitumor Potential
    Ferreira, Elthon G.
    Wilke, Diego V.
    Jimenez, Paula C.
    de Oliveira, Julieta R.
    Pessoa, Otilia Deusdenia L.
    Silveira, Edilberto R.
    Viana, Francisco A.
    Pessoa, Claudia
    de Moraes, Manoel Odorico
    Hajdu, Eduardo
    Costa-Lotufo, Leticia Veras
    [J]. CHEMISTRY & BIODIVERSITY, 2011, 8 (08) : 1433 - 1445
  • [5] Synthesis and biological evaluation of rhodanine derivatives bearing a quinoline moiety as potent antimicrobial agents
    Guo, Meng
    Zheng, Chang-Ji
    Song, Ming-Xia
    Wu, Yan
    Sun, Liang-Peng
    Li, Yin-Jing
    Liu, Yi
    Piao, Hu-Ri
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (15) : 4358 - 4361
  • [6] PUBLIC HEALTH China Takes Aim at Rampant Antibiotic Resistance
    Hvistendahl, Mara
    [J]. SCIENCE, 2012, 336 (6083) : 795 - 795
  • [7] Synthesis and biological evaluation of new 2-chloro-3-((4-phenyl-1H-1,2,3-triazol-1-yl)methyl)quinoline derivatives via click chemistry approach
    Kategaonkar, Amol H.
    Shinde, Pravin V.
    Kategaonkar, Atul H.
    Pasale, Sharad K.
    Shingate, Bapurao B.
    Shingare, Murlidhar S.
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (07) : 3142 - 3146
  • [8] Aerosolized plus Intravenous Colistin versus Intravenous Colistin Alone for the Treatment of Ventilator-Associated Pneumonia: A Matched Case-Control Study
    Kofteridis, Diamantis P.
    Alexopoulou, Christina
    Valachis, Antonios
    Maraki, Sofia
    Dimopoulou, Dimitra
    Georgopoulos, Dimitrios
    Samonis, George
    [J]. CLINICAL INFECTIOUS DISEASES, 2010, 51 (11) : 1238 - 1244
  • [9] Structure-Activity Relationships for a Series of Quinoline-Based Compounds Active against Replicating and Nonreplicating Mycobacterium tuberculosis
    Lilienkampf, Annamaria
    Mao, Jialin
    Wan, Baojie
    Wang, Yuehong
    Franzblau, Scott G.
    Kozikowski, Alan P.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (07) : 2109 - 2118
  • [10] Has the era of untreatable infections arrived?
    Livermore, David M.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 64 (04) : 29 - 36